Solution-focused therapy to improve psychosocial adjustment and medication adherence for people with schizophrenia
Official title: The Effects of a Solution-Focused Approach on Psychosocial Adjustment and Treatment Compliance in Individuals Diagnosed With Schizophrenia
Run by Muş Alparslan University · NCT07144592 · Data updated 2026-11-12
This program will try weekly one-on-one solution-focused therapy for six weeks to see if it helps adults with stable schizophrenia improve social adjustment and stick to their medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Muş Alparslan University Academic / other |
| Locations | 1 site (Muş) |
| Status | Recruiting |
| Started | January 1, 2025 |
| Main results expected | February 25, 2025 |
| Study ends | October 25, 2025 |
| Registry record updated | August 27, 2025 |
| Trial ID | NCT07144592 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with a DSM-5 diagnosis of schizophrenia who are clinically stable, literate and verbally communicative, cognitively able to participate, currently on psychiatric treatment and registered at the participating Community Mental Health Center are ideal candidates.
✕Probably not a fit
People experiencing acute psychosis, significant cognitive impairment, not registered at the participating center, not currently on medication, or outside the 18–65 age range are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled trial enrolling 60 clinically stable adults with DSM-5 schizophrenia who are registered at a university-affiliated Community Mental Health Center in Muş, Türkiye. Participants are randomized to receive one individual solution-focused therapy session per week for six weeks plus usual care, or to receive usual care alone. Outcomes include measures of psychosocial adjustment and medication adherence collected before and after the intervention using validated scales. The intervention emphasizes individual strengths, past coping successes, and brief goal-focused strategies delivered by mental health staff.
Why it matters
Potential benefit: If effective, the approach could help patients improve daily functioning and medication adherence with a brief, low-intensity therapy that can be delivered in community settings.
How similar studies have gone: Small trials and pilot work using solution-focused or brief strengths-based approaches in mental health have shown promise, but rigorous randomized evidence specifically in schizophrenia is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria, Being between 18 and 65 years of age, Being literate and verbally communicative, Being clinically stable (not exhibiting symptoms of acute psychosis), Being registered with a Community Mental Health Center (CMHC) and receiving regular services, Being cognitively competent enough to participate in individual interviews during the research process, Being an individual currently receiving psychiatric treatment and taking medication, Agreeing to participate voluntarily in the study and signing a written informed consent form. Exclusion Criteria: * those who do not meet the inclusion criteria
Where it's running
-
Community Mental Health Center
Muş, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Fatih Şahin, dr
- Email: fatih.sahin@alparslan.edu.tr
- Phone: 0534 688 1634
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive Tasks and Models in a Large Online Sample
This study tests cognitive tasks and computational models in a large online group to see if these tools can help predict symptoms like hallucinations and delusions in the general population.
-
Can seven tasks help distinguish schizophrenia and schizoaffective disorder from healthy people
The study tests seven cognitive tasks to see if they can tell apart people with schizophrenia or schizoaffective disorder from healthy adults and predict symptoms like hallucinations and delusions.
-
See if an early-detection program reduces time to treatment for first-episode psychosis
We test whether a large, region-wide early-detection program can shorten the time from first psychotic symptoms to treatment and help people function better later.
-
Impact of Food Help on Adherence to Cancer Treatment
This study tests whether providing food assistance helps adults with cancer who have food insecurity stick to their treatment plans.
-
mHealth tool to boost hormone therapy adherence for Latina breast cancer patients
A bilingual, culturally tailored smartphone app plus patient navigation is tested to help Latina women on hormone therapy take their medication as prescribed.
-
Gamma brain-feedback to boost working memory in schizophrenia
This trial tests whether real-time gamma EEG neurofeedback helps people with schizophrenia or schizoaffective disorder improve working memory.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.